Clinical Trial Update: A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart [Phase 4]

View source ↗

Summary

Phase 4 trial update of apixaban in atrial fibrillation patients at risk for thrombosis following acute coronary syndrome or related interventions; results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Coronary Syndromes

Drugs mentioned

• Apixaban (apixaban)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Acute Coronary Syndromes | Phase 4 | Status: COMPLETED | Results posted: 2020-02-07